Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Maryland Oncology Hematology, PA
Psilocybin in Depression Resistant to Standard Treatments
King's College London
Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)
University of Cincinnati
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
NeuroRx, Inc.
Ketamine for Major Depressive Disorder
Shenox Pharmaceuticals, LLC
Ketamine Co-induction for Patients With Major Depressive Disorder
University of Saskatchewan
Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression
University of Manitoba
Emergency Ketamine Treatment of Suicidal Ideation
University of Cincinnati
Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
Medical University of Vienna
An Open Prospective Trial of IV Ketamine in Suicidal Adolescents
Nationwide Children's Hospital
Psilocybin for Major Depressive Disorder
Washington University School of Medicine
PET Synaptogenesis After Psilocybin In DEpression Recovery
Washington University School of Medicine
Effect of SSRIs on Response to Psilocybin Therapy
Cybin Therapeutics Inc.
A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression
Janssen Research & Development, LLC
Preoperative Ketamine and Perioperative Depression
Northwestern University
ECT vs. Esketamine
Medical University Innsbruck
Low Dose Ketamine Infusion for the Treatment of Resistant Depression
Loma Linda University
Intravenous Ketamine Effects on Functional Neuroanatomy
Neurological Associates of West Los Angeles
Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department
Maria Pacella
Endogenous Opioid Modulation by Ketamine
University of Utah
Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
William V. Bobo, M.D.
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Cedars-Sinai Medical Center
A Study to Decrease Suicidal Thinking Using Ketamine
United States Naval Medical Center, San Diego
Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
Massachusetts General Hospital
Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
Massachusetts General Hospital
Trial of Ketamine and Lithium Therapy in Bipolar Depression
Yale University
Ketamine Frequency Treatment for Major Depressive Disorder
Essentia Health
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.